UK pushes veterinary reforms tied to pet care costs

The UK is moving toward a sweeping rewrite of veterinary regulation, with ministers framing reform as both a consumer protection issue and a response to mounting concern over pet care costs. A UK-wide consultation on reform of the Veterinary Surgeons Act 1966 closed on March 25, 2026, after proposing changes that would regulate veterinary businesses, modernize licensing and fitness-to-practise systems, and bring more of the veterinary team under formal oversight. The policy push has landed while the Competition and Markets Authority, or CMA, is still finalizing its own investigation into the household pet veterinary market. (gov.uk)

The backdrop is a long-running debate over whether the UK’s legal framework still fits a modern veterinary sector. The current Veterinary Surgeons Act dates to 1966, and multiple bodies have argued for years that it no longer reflects how care is delivered, how practices are owned, or how teams are structured. The CMA added urgency in 2024 when it escalated its review into a full market investigation, citing concerns about weak competition, limited pricing transparency, and the growing role of large corporate groups in practice ownership. The regulator later extended that investigation in June 2025, moving the final deadline to May 2026. (gov.uk)

The government’s consultation made clear that reform is not limited to pet pricing, even if affordability helped drive the political momentum. According to Defra and a related written ministerial statement, the proposals include a licence-to-practise model, stronger fitness-to-practise rules, regulation of veterinary and animal healthcare businesses, and updates to the regulator’s governance. Ministers also tied the reforms to workforce pressures, arguing that allowing veterinary nurses to work more independently could improve retention and free veterinarians to focus on higher-complexity work. They also said better regulation of businesses and clearer pricing could improve consumer protection and competition. (gov.uk)

Meanwhile, the CMA’s provisional remedy package goes further into day-to-day commercial operations. In October 2025, it proposed measures that would require practices to publish more complete price information, provide written prices for higher-cost treatment, disclose ownership, improve complaints processes, and make it easier for pet parents to shop around for medicines. Reporting around the proposal also noted a suggested cap on written prescription charges and the possibility of more formal operating licences for practices. The CMA has described the veterinary services market as worth £6.3 billion in 2024 and said fee growth had outpaced inflation significantly. (gov.uk)

Reaction across the profession has been supportive in principle, but cautious on implementation. The RCVS said Defra’s consultation incorporated many of its longstanding recommendations, including statutory powers to regulate veterinary businesses, title protection for veterinary nurses, wider regulation of allied professionals, and a more modern registration and licensing system. RCVS President Tim Parkin called it a “once-in-a-generation opportunity” to put the sector on a firmer regulatory footing. (rcvs.org.uk)

Independent practice groups have been more guarded. The Federation of Independent Veterinary Practices said it supports transparency remedies and agrees that a new Veterinary Surgeons Act is needed, but warned that some CMA proposals could have unintended consequences. In particular, FIVP argued that if practices lose medicine income to lower-cost online pharmacies, some may need to raise fees for other services or risk closure. A joint response from major veterinary organizations similarly backed written estimates, itemized bills, and clearer complaints systems, while opposing requirements they see as overly burdensome or economically unrealistic, including a prescription fee cap below the market median. (fivp.org.uk)

Why it matters: For veterinary professionals, the significance here is structural. If the UK moves ahead, accountability would increasingly attach not just to individual vets and nurses, but to the businesses, systems, and incentives around them. That could reshape compliance, pricing communication, complaints management, medicines revenue, workforce deployment, and the legal status of veterinary nurses and allied roles. It also signals a policy direction that other markets, including the US, may watch closely: when affordability concerns collide with corporate consolidation and opaque pricing, regulators may look beyond professional conduct and into business model design. That inference is supported by the CMA’s focus on ownership, medicines, and consumer choice, and by Defra’s explicit argument that competition and regulation should work together. (hansard.parliament.uk)

What to watch: The immediate milestones are the UK government’s response to the now-closed consultation and the CMA’s final veterinary market decision, which must be completed by May 2026; after that, the key question will be which reforms require legislation, which can be implemented through regulatory change, and how quickly practices will be expected to adapt. (gov.uk)